Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02684097
Recruitment Status : Completed
First Posted : February 17, 2016
Last Update Posted : April 22, 2019
Sponsor:
Information provided by (Responsible Party):
Emma.Guttman, Icahn School of Medicine at Mount Sinai

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : November 28, 2017
Actual Study Completion Date : November 28, 2017
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 October 29, 2019
November 18, 2019